BRUKER CORPORATION Effective Income Tax Rate Reconciliation, Tax Contingency, Percent
BRUKER CORPORATION (BRKR) reported Effective Income Tax Rate Reconciliation, Tax Contingency, Percent of 3.00% for the 3-month period ending 2025-09-30, per its 10-Q filed 2025-11-05.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationTaxContingencies · last filed 2026-02-27
- BRUKER CORPORATION effective income tax rate reconciliation, tax contingency, percent for the quarter ending 2025-09-30 was 3.00%.
- BRUKER CORPORATION effective income tax rate reconciliation, tax contingency, percent for the quarter ending 2025-06-30 was 2.30%.
- BRUKER CORPORATION effective income tax rate reconciliation, tax contingency, percent for the quarter ending 2025-03-31 was 2.10%.
- BRUKER CORPORATION effective income tax rate reconciliation, tax contingency, percent for fiscal 2024 was 2.20%.
- BRUKER CORPORATION effective income tax rate reconciliation, tax contingency, percent for fiscal 2023 was 0.00%, a 100.00% decline from fiscal 2022.
- BRUKER CORPORATION effective income tax rate reconciliation, tax contingency, percent for fiscal 2022 was 3.30%, a 26.92% increase from fiscal 2021.
- BRUKER CORPORATION effective income tax rate reconciliation, tax contingency, percent for fiscal 2021 was 2.60%, a 85.71% increase from fiscal 2020.
| Period end | Effective Income Tax Rate Reconciliation, Tax Contingency, Percent 3 month | Effective Income Tax Rate Reconciliation, Tax Contingency, Percent 6 month | Effective Income Tax Rate Reconciliation, Tax Contingency, Percent 9 month | Effective Income Tax Rate Reconciliation, Tax Contingency, Percent 12 month |
|---|---|---|---|---|
| 2025-09-30 | 3.00% 10-Q · filed 2025-11-05 | 3.00% 10-Q · filed 2025-11-05 | ||
| 2025-06-30 | 2.30% 10-Q · filed 2025-08-06 | 2.30% 10-Q · filed 2025-08-06 | ||
| 2025-03-31 | 2.10% 10-Q · filed 2025-05-07 | |||
| 2024-12-31 | 2.20% 10-K · filed 2026-02-27 | |||
| 2023-12-31 | 0.00% 10-K · filed 2026-02-27 | |||
| 2022-12-31 | 3.30% 10-K · filed 2025-03-03 | |||
| 2021-12-31 | 2.60% 10-K · filed 2024-02-29 | |||
| 2020-12-31 | 1.40% 10-K · filed 2023-03-01 | |||
| 2019-12-31 | 1.40% 10-K · filed 2022-02-28 | |||
| 2018-12-31 | 0.90% 10-K · filed 2021-03-01 | |||
| 2017-12-31 | -1.30% 10-K · filed 2020-03-27 | |||
| 2016-12-31 | -3.00% 10-K · filed 2019-03-01 | |||
| 2015-12-31 | 2.30% 10-K · filed 2018-03-16 | |||
| 2014-12-31 | -0.90% 10-K · filed 2017-03-01 | |||
| 2013-12-31 | -1.10% 10-K · filed 2016-02-29 | |||
| 2012-12-31 | 3.00% 10-K · filed 2015-02-27 | |||
| 2011-12-31 | 6.10% 10-K · filed 2014-02-27 | |||
| 2010-12-31 | 4.40% 10-K · filed 2013-02-28 | |||
| 2009-12-31 | 2.40% 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |